网站主页>>>项目整合精选>>>项目整合精选>>>新产品编号:1702741

新产品编号:1702741

Chemical Name: 3(R)-(Cyclopentylmethyl)-2(R)-[N-methyl-N-(methylsulfonyl)aminomethyl]-4-oxo-4-(1-piperidinyl)butyrohydroxamic acid
项目整合开发状态: Preclinical
项目研究机构: British Biotech (Originator)
合成路线:The intermediate amide (IV) can be obtained by two related methods.The homochiral methylenesuccinate (I) was coupled with piperidine (II) in the presence of EDC and HOBt to afford amide (III).Subsequent stereoselective conjugate addition of methylamine produced the (R,R)-amine (IV).In a related procedure,conjugate addition of methylamine to unsaturated ester (V) gave adduct (VI).Acid cleavage of the tert-butyl ester of (VI) generated carboxylic acid (VII),which was then coupled with piperidine (II) to provide (IV).Sulfonamide (VIII) was prepared by condensation of amine (IV) with methanesulfonyl chloride.Hydrogenolysis of the benzyl ester of (VIII) yielded acid (IX),which was finally coupled with hydroxylamine producing the title hydroxamic acid.
📌 参考资料/链接:
参考文献标题:The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors
文献作者:Martin,F.M.; Beckett,R.P.; Bellamy,C.L.; Courtney,P.F.; Davies,S.J.; Drummond,A.H.; Dodd,R.; Pratt,L.M.; Patel,S.R.; Ricketts,M.L.; Todd,R.S.; Tuffnel,A.R.; Ward,J.W.; Whittaker,M.
参考来源:Bioorg Med Chem Lett 1999,9(19),2887